These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15660747)

  • 21. [Atherosclerosis in diabetes mellitus].
    Stange EF
    Internist (Berl); 1989 May; 30(5):297-303. PubMed ID: 2661472
    [No Abstract]   [Full Text] [Related]  

  • 22. Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid.
    Cardiovasc J Afr; 2008; 19(3):171-2. PubMed ID: 18568186
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
    Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk factors for the development of microalbuminuria in type 1 diabetes: an incidence cohort study--a secondary publication].
    Hovind P; Tarnow L; Rossing P; Jensen BR; Graae M; Torp I; Binder C; Parving HH
    Ugeskr Laeger; 2005 Jan; 167(1):57-60. PubMed ID: 15675170
    [No Abstract]   [Full Text] [Related]  

  • 25. [Identification and prevention of vascular risk. Significance of metformin].
    Isnard F; André P
    Journ Annu Diabetol Hotel Dieu; 1990; ():311-23. PubMed ID: 2195214
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter by Eller et al regarding article, "Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland".
    Eller K; Tancevski I; Eller P
    Circulation; 2010 Apr; 121(14):e377. PubMed ID: 20385959
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis.
    Pappachan JM; Sebastian J; Bino BC; Jayaprakash K; Vijayakumar K; Sujathan P; Adinegara LA
    Postgrad Med J; 2008 Apr; 84(990):205-10. PubMed ID: 18424578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the understanding of diabetic vascular disease.
    Fujii S
    J Cardiovasc Risk; 1997 Apr; 4(2):67-9. PubMed ID: 9304486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanism of coronary heart disease in diabetes].
    Ito H
    Nihon Rinsho; 2010 May; 68(5):772-5. PubMed ID: 20446568
    [No Abstract]   [Full Text] [Related]  

  • 31. Diabetes: a risk factor for glaucoma?
    Primus S; Harris A; Siesky BA; Guidoboni G
    Br J Ophthalmol; 2011 Dec; 95(12):1621-2. PubMed ID: 21979896
    [No Abstract]   [Full Text] [Related]  

  • 32. Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes.
    Byrne CD
    Diabetes Obes Metab; 2004 Jul; 6(4):308-9. PubMed ID: 15171756
    [No Abstract]   [Full Text] [Related]  

  • 33. [Validity of the Framingham-REGICOR and DORICA coronary risk equations for a health centre's diabetic population].
    Cañón Barroso L; Cruces Muro E; Fernández Gómez A; Buitrago Ramírez F
    Aten Primaria; 2006 Sep; 38(4):241-2. PubMed ID: 16978567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate.
    Evans M; McEwan P; Peters JR; Currie CJ
    Diabetes Obes Metab; 2004 Jul; 6(4):299-307. PubMed ID: 15171755
    [No Abstract]   [Full Text] [Related]  

  • 35. Microvascular disease in diabetes mellitus.
    Kollros PR; Konkle BA
    J Cardiovasc Risk; 1997 Apr; 4(2):70-5. PubMed ID: 9304487
    [No Abstract]   [Full Text] [Related]  

  • 36. [Microangiopathic complications in type 2 diabetes].
    Strojek K; Grzeszczak W
    Wiad Lek; 1998; 51 Suppl 2():45-51. PubMed ID: 9686533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sweet heart - contributions of metabolism in the development of heart failure in diabetes mellitus.
    Stratmann B; Tschoepe D
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S40-5. PubMed ID: 18777453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ischemic heart disease and diabetes mellitus].
    Sokhor K
    Voen Med Zh; 1982 Nov; (11):58-9. PubMed ID: 7179789
    [No Abstract]   [Full Text] [Related]  

  • 39. [Genetic aspects of diabetes mellitus and diabetic angiopathies].
    Efimov AS
    Vestn Akad Med Nauk SSSR; 1986; (9):49-54. PubMed ID: 3788275
    [No Abstract]   [Full Text] [Related]  

  • 40. Heme iron from diet as a risk factor for coronary heart disease in women with type 2 diabetes.
    Qi L; van Dam RM; Rexrode K; Hu FB
    Diabetes Care; 2007 Jan; 30(1):101-6. PubMed ID: 17192341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.